Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut hole.” ...

Eligible patients in the expanded access program will be able to receive daraxonrasib from their healthcare provider ...

The FDA said the action recognizes the dire need for a drug to improve survival for pancreatic cancer patients, who face the ...

The agency is broadening eligibility for an international trade loan program as small businesses grapple with stubbornly high ...

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.

A federal appeals court temporarily halted a Food and Drug Administration regulation that has greatly expanded access to the ...

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the launch of a U.S. Expanded Access Program (EAP) for up to 250 adults with post-bariatric hypoglycemia (PBH) ...

Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain.

Abridge's nursing platform was "absolutely" a bigger challenge than the physician equivalent, Dr. Shiv Rao told Newsweek.

Republican lawmakers file Supreme Court brief alleging loosened mifepristone rules enabled coercion, backing Louisiana's ...

The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug ...

US FDA permits expanded access for investigational pancreatic cancer drug, daraxonrasib: Silver Spring, Maryland Monday, May 4, 2026, 12:00 Hrs [IST] The US Food and Drug Administ ...